TO Pharma
About TO Pharma
TO Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing therapeutics based on its proprietary cannabinoid product platform in a number of FDA-regulated clinical indications and in select OTC markets.
Missing: TO Pharma's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: TO Pharma's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing TO Pharma
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
TO Pharma is included in 1 Expert Collection, including Cannabis.
Cannabis
3,834 items
These companies participate in - or service businesses that participate in - the legal cannabis industry. Our definition of cannabis includes both marijuana and hemp (and all derivatives). The collection includes both "plant-touching" and "non-plant-touching" businesses.
TO Pharma Patents
TO Pharma has filed 4 patents.
The 3 most popular patent topics include:
- Cannabinoids
- Designer drugs
- Phenols
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
3/28/2017 | Cannabinoids, Designer drugs, Inflammations, Phenols, Autoimmune diseases | Application |
Application Date | 3/28/2017 |
|---|---|
Grant Date | |
Title | |
Related Topics | Cannabinoids, Designer drugs, Inflammations, Phenols, Autoimmune diseases |
Status | Application |
Latest TO Pharma News
May 18, 2023
| 17 May 2023 | Joe Biden this week nominated cancer specialist Dr. Monica Bertagnolli for director of the National Institutes of Health (NIH) -- a move that has already generated controversy because of Bertagnolli's longstanding financial ties to Pfizer and other pharmaceutical companies. Bertagnolli is director of the National Cancer Institute (NCI), the largest of the 19 institutes and seven centers under the aegis of the NIH... Under Bertagnolli's leadership, the Alliance for Clinical Trials in Oncology has received more than $323 million in funding from Pfizer and other Big Pharma firms, according to Open Payments data revealed by The Daily Signal and The Heritage Foundation's Oversight Project. In a series of tweets, Robert F. Kennedy, Jr., Children's Health Defense chairman on leave and Democratic candidate for president in 2024, criticized Bertagnolli's nomination. "The White House left the Pfizer connection out of its announcement of the nomination. Does this mean Dr. Bertagnolli is personally corrupt? Not at all. But it does mean that she will probably represent the viewpoints and priorities of the pharmaceutical industry. That is how agencies are captured," Kennedy wrote .
TO Pharma Frequently Asked Questions (FAQ)
Where is TO Pharma's headquarters?
TO Pharma's headquarters is located at 2150 Cabot Blvd West, Langhorne.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.